Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, May 21, 2026

Snapshot: May 21, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Thu, May 21, 2026 Divergent High

Russell 2000 surged nearly 1% while S&P and Nasdaq barely budged, but wild single-stock dispersion—with 37 gainers averaging +250%—told the real story of quantum computing fervo…

55% Extreme dispersion defined the day as 37 of the top 50 gainers rocketed an average +250%, with quantum stocks soaring on $2 billion in Trump administration CHIPS Act grants (QBTS +33%, RGTI +31%, INFQ +31%) and biotech names like CODX (+55% on a $3M capital raise) and AKTX (+50% on pancreatic cancer synergy data) leading the charge. HAO's inexplicable 10,821% spike and QBTZ's inverse collapse underscore the wild leverage and low-liquidity chaos that dominated tape action.
30% Small-cap strength drove Russell 2000 to a rare +0.93% gain despite S&P 500 flatness (+0.18%) and Nasdaq weakness (+0.09%), signaling a tactical rotation into beaten-down micro and penny stocks rather than broad-based market conviction. VIX fell nearly 4%, suggesting complacency rather than fear despite the violent single-stock moves.
15% Five debutants and a persistent 7-day loser streak in WOK highlight a bifurcated market where distressed names and quantum/AI darlings dominated headlines; Financial Services led losers with 26% of the decline count, while Technology captured 34% of gainers, reflecting sector-specific momentum unmoored from macro fundamentals.

Technology drove 34% of gainers WOK on a 7-day losers streak 5 names returned after long absences WOK · 7-day losers streak LICN · 4-day losers streak ATPC — first appearance

Market Regime

Thu, May 21, 2026 Risk-On conf: high macro · prototype

+28

Tailwind −100 … +100 · + tailwind / − headwind

VIX16.8 p41 Drawdown-0.7% Held1d · nascent SinceMay 21

Top drivers: S&P vs 50d avg ▲ S&P 20d return ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Thu, May 21, 2026 4

S&P 500

7,446.05

+13.08

+0.18%

NASDAQ Composite

26,293.10

+22.74

+0.09%

Russell 2000

2,843.45

+26.08

+0.93%

VIX

16.76

−0.68

-3.90%

Biggest Gainers

Thu, May 21, 2026 50

HAO

Haoxi Health Technology LimitedCommunication Services

$1.54+$1.53

+10,822.0%

NASDAQ · Mkt cap $1.4 M

No news headlines were found in the last 48 hours for HAO, so the 10,821% gain cannot be attributed to a specific disclosed catalyst. The move likely reflects a penny-stock technical or speculative event such as a short squeeze, delayed news pickup, or algorithmic reversal.

The absence of any recent news in the 48-hour window is notable given the extreme magnitude of the gain. A move of this scale in a low-priced equity typically occurs either when a material news event fails to appear in real-time feeds due to timing or indexing delays, when a stock has been heavily shorted and a technical trigger forces a squeeze, or when algorithmic or retail trading creates momentum in thinly traded securities. Haoxi Health Technology is a small-cap NASDAQ-listed company, making it a candidate for speculative repositioning. Without confirmed news, the cause remains speculative, but the pattern is consistent with short-covering, a delayed earnings or corporate announcement that the RSS feed has not yet captured, or pure momentum trading in a micro-cap name.

NCPL

Netcapital Inc.Financial Services

$0.82+$0.37

+80.7%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 80.66% jump cannot be attributed to a documented public announcement or earnings event. The move likely reflects technical or speculative activity common in low-priced micro-cap stocks.

Despite NCPL ranking as the second-largest gainer on the day with an 80.66% surge, no recent headlines from Yahoo Finance RSS appear in the provided data. This absence of news coverage for such a dramatic move is notable. For a micro-cap stock trading at $0.82, price swings of this magnitude can occur from multiple sources: short covering or a short squeeze, retail trading enthusiasm on social platforms, options-related gamma activity, or delayed market reactions to announcements made outside mainstream financial feeds. Without documented news, we cannot isolate a specific catalyst. The stock's low price point makes it susceptible to fractional-share trading and volatility unmoored from fundamental events. It is also possible the news existed but was not captured by this particular data source.

ATPC

Agape ATP CorporationConsumer Defensive

$3.59+$1.50

+71.8%

NASDAQ · Mkt cap $2.5 M

No news headlines were found in the last 48 hours to explain ATPC's 71.77% surge, so the driver remains unclear. The jump may reflect a delayed market reaction to an untracked announcement, technical trading activity, or retail speculation.

The absence of any recent news in the provided sources creates genuine ambiguity about what triggered a third-ranking daily gain of over 71%. For a small-cap stock like ATPC trading near $3.59, potential catalysts typically include clinical trial results or regulatory approvals (if it's biotech), contract wins or operational milestones, insider trading activity, short squeeze dynamics, or simply algorithmic/retail momentum in a lightly traded security. Without corroborating headlines, earnings reports, or SEC filings in the snapshot, we cannot distinguish between a real fundamental event that went unreported by Yahoo Finance RSS, a technical rebound after oversold conditions, or momentum-driven speculation. The 48-hour news window may also have missed an announcement that moved the market earlier.

AKAN

Akanda Corp.Healthcare

$23.46+$8.95

+61.7%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours to explain AKAN's 61.68% surge, so the driver remains unclear without additional context on market events, earnings, or company announcements that may have occurred.

The absence of headlines in the Yahoo Finance RSS feed over the last 48 hours makes it impossible to identify a specific news-driven catalyst for this substantial gain. AKAN, a cannabis and hemp company, could have experienced a rally for several reasons typical of the sector: potential positive regulatory developments, short-squeeze activity, sector-wide momentum shifts, insider buying announcements, or delayed earnings results not yet reflected in headlines. The stock's rank as the fourth biggest gainer suggests meaningful volume and price action. Without corroborating news, any explanation remains speculative. It is also possible that relevant announcements were made but not yet picked up by the RSS feed, or that the move was primarily technical or sentiment-driven rather than news-driven.

RGTX

Daily Target 2X Long RGTI ETFFinancial Services

$29.10+$11.02

+61.0%

PCLA

PicoCELA Inc.Communication Services

$2.25+$0.85

+60.7%

NASDAQ · Mkt cap $62 M

No news headlines are available for the last 48 hours, so the 60.7% surge cannot be attributed to a specific announced event. The move likely reflects a technical bounce, delayed news release, or market speculation in a micro-cap stock.

PicoCELA Inc. is a NASDAQ-listed micro-cap stock that jumped 60.7% to $2.25 with no identifiable news catalyst in the most recent 48-hour window. This absence of reported headlines is the critical constraint here. For a stock moving this sharply in a single day, typical catalysts would include earnings surprises, clinical trial results (if biotech), partnership announcements, or short covering in a thinly traded security. Without access to company filings, social media chatter, or broader market context, we cannot rule out possibilities such as a delayed press release that did not appear in the Yahoo Finance RSS feed, a technical rebound in a volatile stock, short-squeeze activity, or momentum trading by retail investors. The lack of fundamental news does not prove the move is unfounded, only that the evidence record is incomplete.

CODX

Co-Diagnostics, Inc.Healthcare

$3.71+$1.32

+55.2%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics announced a $3.0 million at-the-market private placement on May 20, which likely triggered the 55% gain as investors interpreted the capital raise as a vote of confidence in the company's molecular diagnostics platform and future prospects.

The headline from May 20 establishes that Co-Diagnostics entered into a private placement priced at-the-market under Nasdaq rules for $3.0 million. For a small-cap molecular diagnostics company, a capital raise can signal management confidence in near-term execution and reduce immediate dilution concerns relative to larger raises. The timing and announcement style suggest the company secured funding to advance its patented diagnostic platform. However, the headline is truncated and does not provide detail on use of proceeds, strategic rationale, or investor composition. The magnitude of the move (55%) is substantial for a simple funding announcement, suggesting either the market had been awaiting capital confirmation, there is additional positive context in the full release not captured here, or broader sentiment toward the diagnostics sector shifted positively on this date.

AMPGR

Amplitech Group, Inc. Series A Right

$0.87+$0.31

+54.9%

NASDAQ

AmpliTech jumped 55% following FCC and Canadian regulatory approval for its 5G infrastructure platform announced May 20, combined with strong Q1 earnings (48.6% revenue growth) and a Northeastern University partnership announcement on May 21, removing commercialization barriers for its Pico Radio…

The stock rallied on a confluence of positive catalysts over two days. The May 20 FCC and Innovation, Science and Economic Development Canada certifications cleared the end-to-end hardware stack for immediate commercial sale and deployment in U.S. and Canadian markets, removing a key regulatory risk that had likely constrained investor confidence. The same day, premarket reaction was already +14%, but continued buying on May 21 suggests accumulation following the Q1 earnings report showing 48.6% revenue surge and margin improvements, plus the Northeastern University demonstration of the company's 5G 64T64R MIMO platform. Together these events signal both demand validation and regulatory de-risking, which can trigger significant repricing in micro-cap RF component stocks with limited float.

NIVF

NewGenIvf Group LimitedHealthcare

$1.12+$0.38

+51.5%

NASDAQ · Mkt cap $3.5 M

NewGenIVF announced a strategic $2 million investment in K25.ai, a prediction market platform valued at $100 million, with an option to invest up to $10 million total, likely triggering the 51% rally on growth and diversification into AI and fintech.

The two news items released on May 21 describe NewGenIVF's entry into a strategic investment partnership with K25.ai, an APAC-focused AI-native live streaming and prediction market platform. NewGenIVF is making an initial $2 million investment at a $100 million pre-money valuation for K25.ai, with an option to deploy up to $10 million if exercised in full. The announcement also notes an exclusive APAC agency partnership providing NewGenIVF exposure to what is described as positioning K25.ai for a future public listing. For a smaller-cap biotech or specialty healthcare company like NewGenIVF, a pivot into high-growth AI and fintech exposure through a strategic investment in a venture-backed platform can appeal to growth-oriented investors, particularly if the market views this as a portfolio diversification or new revenue stream opportunity. The magnitude of the gain suggests the market is viewing this favorably relative to NewGenIVF's prior business profile.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.98+$0.33

+50.8%

NASDAQ

AmpliTech's 50.77% gain was driven by FCC and Canadian regulatory approval for its Pico Radio 5G infrastructure platform announced May 20, combined with strong Q1 2026 earnings (48.6% revenue growth) and a tech demonstration partnership at Northeastern University on May 21.

The stock benefited from multiple positive catalysts converging within 48 hours. The headline catalyst was regulatory approval from the FCC and Canadian authorities for the company's end-to-end 5G Pico Radio hardware stack, which clears the path for immediate commercial deployment in two major markets. This was preceded by Q1 earnings results showing robust 48.6% revenue growth and margin improvements, signaling strong business momentum despite acknowledged geopolitical and supply chain headwinds. On May 21, a third positive anchor arrived: AmpliTech's 5G 64T64R MIMO platform was selected to support a Northeastern University AI-enabled wireless infrastructure research demonstration, providing validation from a tier-one research institution and potentially opening future deployment opportunities in the emerging AI-RAN (AI Radio Access Network) space. AMPGZ is a Series B right offering, which means it tracks the underlying AMPG common stock and would amplify moves proportionally.

AKTX

Akari Therapeutics, PlcHealthcare

$5.14+$1.71

+49.9%

NASDAQ · Mkt cap $14 M

Akari Therapeutics announced breakthrough preclinical data showing synergistic activity of its AKTX-101 candidate with KRAS inhibitors in pancreatic cancer models, alongside a $5.5 million private placement, driving a nearly 50% single-day gain.

The company released two material announcements on May 21st. The primary catalyst appears to be the preclinical data demonstrating that AKTX-101, an antibody-drug conjugate with a novel RNA spliceosome-modulating payload, shows synergistic cytotoxic activity when paired with KRAS inhibitors against KRAS G12D and G12C-driven pancreatic cancer models. This represents a potential therapeutic advantage in a high-value oncology indication. Simultaneously, the $5.5 million private placement offering signals management confidence and provides near-term funding runway. For early-stage biotech stocks with limited commercial revenue, positive preclinical efficacy data—especially synergy with an established drug class—can justify substantial valuation moves as it advances the clinical narrative and de-risks development timelines. The combination of scientific validation and capital raise likely drove investor enthusiasm.

PIII

P3 Health Partners Inc.Healthcare

$13.86+$4.17

+43.0%

NASDAQ · Mkt cap $1.8 B

No headlines were found in the last 48 hours to explain PIII's 43% gain on May 21, 2026, so the catalyst remains unknown without additional reporting or company announcements.

P3 Health Partners is a physician-led healthcare services company that operates urgent care and primary care centers. A 43% intraday surge with zero news coverage in the trailing two days is unusual and suggests either delayed reporting of material information, an after-hours or pre-market announcement not yet picked up by RSS feeds, technical trading activity, short covering, or market reaction to broader healthcare sector tailwinds. Healthcare stocks have shown sensitivity to policy shifts, reimbursement changes, and M&A activity. Without confirmed headlines, the specific driver cannot be identified. It is also possible that news was released outside the monitored news window or via channels not captured in the Yahoo Finance RSS source provided.

SBFM

Sunshine Biopharma, Inc.Healthcare

$0.52+$0.15

+40.6%

NASDAQ · Mkt cap $4.5 M

Sunshine Biopharma announced Canadian regulatory approval for generic amoxicillin on May 21, driving a 40.59% single-day gain as the news hit the market.

The company released a press statement on May 21 at 11:00 UTC announcing that it had received Canadian regulatory approval for a generic amoxicillin product. For a small-cap generic pharmaceutical company trading at $0.52, a new regulatory milestone approving a product to enter the Canadian market represents a concrete expansion of its commercial opportunities and revenue-generating capacity. Generic amoxicillin is a widely prescribed antibiotic with established demand, so approval signals the company can now legally manufacture and sell into that jurisdiction. The 40.59% single-day jump is consistent with how micro-cap and small-cap pharma stocks respond to regulatory green lights, which remove execution risk and open a new revenue stream. The stock ranked as the 13th biggest gainer of the day, reflecting broad market attention to the news.

LAFAR

LaFayette Acquisition Corp. Rights

$0.11+$0.03

+37.5%

NASDAQ

No news headlines were found in the last 48 hours, but the 37.50% jump in LAFAR rights on low absolute price likely reflects either a technical rally in microcap securities, speculation tied to the underlying acquisition target, or delayed market reaction to a prior announcement not captured in t…

The absence of recent news headlines makes direct attribution impossible. However, LAFAR is a SPAC rights offering, a security class known for extreme volatility and price swings driven by factors other than traditional corporate events: retail speculation, technical levels on micro-cap securities, changes in the probability or terms of the proposed merger with the target company, or redemption dynamics as the deal approaches a vote or deadline. Rights offerings are also sensitive to changes in investor sentiment toward the broader SPAC market. The 37.50% gain on a stock trading at $0.11 could also reflect a small absolute price movement amplified into a large percentage move, making interpretation of causality particularly difficult without supporting news context.

WHLR

Wheeler Real Estate Investment Trust, Inc.Real Estate

$1.29+$0.35

+37.2%

NASDAQ · Mkt cap $942 K

No news headlines were found in the last 48 hours, so the 37% gain likely reflects a technical bounce, short covering, or an off-exchange announcement not yet indexed by major news feeds.

Wheeler Real Estate Investment Trust is a small-cap REIT trading at $1.29, and the absence of any recent news makes it difficult to pinpoint a specific catalyst. Stocks at this price point and market cap are often thinly traded and susceptible to technical rebounds after selling pressure, short squeezes, or retail accumulation. A 37% single-day move in a micro-cap real estate trust without corresponding headline news suggests either a delayed earnings release or corporate announcement not yet reflected in the news feed, a momentum-driven bounce off technical support, or potentially a low-volume spike that can exaggerate percentage moves. Real estate trusts sometimes also respond to broad sector sentiment shifts or changes in interest rate expectations, though the absence of corroborating financial news makes that pure inference. The gap between the price movement and the news vacuum points toward a micro-cap dynamic rather than fundamental catalyst.

FBYD

Falcon's Beyond Global, Inc. Class A Common StockIndustrials

$19.10+$5.12

+36.6%

NASDAQ · Mkt cap $387 M

Falcon's Beyond announced the listing of its Series B Preferred Stock on Nasdaq on May 21, 2026, coinciding with a 36.62% jump in the Class A common stock price the same day, suggesting investor enthusiasm over the capital raise and expanded exchange presence.

The company announced the listing of Series B Preferred Stock on Nasdaq on the exact date of the price spike. While the headline does not provide full details on the terms, size, or strategic rationale, a preferred stock listing typically signals a capital raise or refinancing event. For a growth-stage entertainment and technology company, this could indicate new funding to support operations, acquisitions, or product development. The timing between announcement and the common stock's sharp gain suggests market participants viewed the news positively, interpreting it as validation of the business or a catalyst for future growth. However, the truncated headline leaves key details unclear, such as the amount raised, pricing relative to common stock, dilution impact, and whether this signals a shift in financial strategy. Investors may also have reacted to the elevated profile of a Nasdaq listing itself.

EDHL

Everbright Digital Holding Limited Ordinary SharesCommunication Services

$2.92+$0.74

+33.9%

NASDAQ · Mkt cap $6.5 M

No news headlines were found in the last 48 hours for EDHL, so the 33.95% gain cannot be directly attributed to a named catalyst. The move was likely driven by technical factors, a delayed announcement, or market rumors not yet reflected in major news feeds.

The absence of any news headlines in the provided RSS feed over the last two days is notable given the magnitude of the price move. A 34% single-day gain typically requires a concrete catalyst such as earnings results, a material acquisition or partnership, FDA approval, guidance revision, or significant insider activity. For a smaller-cap or less widely-covered stock like EDHL trading on NASDAQ, it is possible that relevant news was released through non-traditional channels, via the company's investor relations channels, or through news sources not captured by the Yahoo Finance RSS feed used here. Alternatively, the move could reflect technical trading activity such as short covering, options-driven demand, or retail investor accumulation based on social media discussion or other informal signals. Without access to the company's recent press releases or SEC filings, the specific cause remains unknown.

QBTS

D-Wave Quantum Inc.Technology

$25.72+$6.42

+33.3%

NYSE · Mkt cap $6.2 B

The Trump Administration announced $2 billion in federal grants for quantum computing advancement on May 21, with the Commerce Department planning to take stakes in quantum firms including D-Wave, directly triggering the sector-wide rally and QBTS's 33% gain.

Multiple headlines from May 21 establish that the U.S. Commerce Department announced a $2 billion quantum computing initiative aimed at competing with China, with the federal government expected to take equity stakes in quantum computing companies including D-Wave. This represents substantial government backing and validation of the quantum computing sector. The news triggered immediate rallies across quantum stocks, with D-Wave, Rigetti, and IBM all mentioned as beneficiaries. Analyst commentary from Cantor Fitzgerald noted that quantum technology is approaching commercialization and these companies represent multiple investment winners. The timing is clear—all major headlines cluster on May 21 during market hours, and the stock's 33% single-day gain directly coincides with this announcement. This is a straightforward sector catalyst with direct government commitment rather than speculative activity.

ARMG

Leverage Shares 2x Long ARM Daily ETF

$32.30+$7.89

+32.3%

NASDAQ

No news headlines were found in the last 48 hours, but ARMG is a 2x leveraged long ETF tracking ARM Holdings, so a strong move in ARM stock would naturally amplify to roughly double that percentage gain in the fund.

The absence of recent news headlines prevents a direct causal link to a specific corporate event. However, ARMG's structure as a daily 2x leveraged ETF tracking Arm Holdings provides a mechanical explanation. A roughly 16% rally in ARM stock would translate to approximately a 32% gain in ARMG due to leverage. This suggests that ARM Holdings itself experienced a significant positive catalyst on or shortly before May 21, 2026. Possible drivers for ARM could include strong earnings, positive guidance, major contract wins, improved semiconductor industry sentiment, or technical momentum. Without access to ARM-specific news or broader market context, we cannot identify which of these categories drove the underlying stock, but the magnitude of ARMG's move is entirely consistent with a meaningful move in its reference asset amplified by its 2x daily reset mechanism.

JUNS

Jupiter Neurosciences, Inc.Healthcare

$0.27+$0.07

+32.1%

NASDAQ · Mkt cap $3.7 M

Jupiter Neurosciences announced a $100 million exclusive licensing deal for ALA-002, a next-generation MDMA therapeutic, from PharmAla Biotech on May 20, directly driving the 32% stock gain.

On May 20, Jupiter Neurosciences secured a term sheet to license exclusive U.S. rights to ALA-002, PharmAla's next-generation MDMA-based therapeutic, in a transaction valued at over $100 million. This represents a major strategic asset acquisition for a clinical-stage biotech company and positions Jupiter at the forefront of psychedelic medicine following President Trump's April 18 executive order accelerating development in this field. The company also announced a concurrent $2 million registered direct offering to fund operations. For a micro-cap stock trading at $0.27, a nine-figure licensing agreement with regulatory tailwinds provides both concrete asset value and market sentiment catalysts. The timing and magnitude of the deal announcement on the same day as the stock's 32% gain establishes clear causality.

INFQ

Infleqtion, Inc.Technology

$14.70+$3.52

+31.5%

NYSE · Mkt cap $2.9 B

The Trump administration announced $2 billion in CHIPS Act grants to nine quantum computing companies on May 21st, triggering a broad sector rally that lifted INFQ 31.48% as a pure-play quantum firm positioned to benefit from federal backing and commercialization trends.

Multiple news sources confirm that on May 21st, 2026, the Trump administration awarded $2 billion in grants to nine quantum computing firms, with IBM receiving $1 billion and the government taking minority equity stakes in recipients. The announcement explicitly frames quantum computing as a strategic technology in competition with China and signals that the sector has moved from experimental science into policy-backed commercialization. INFQ, described in one headline as a quantum hardware, software, and sensing company already launching technology into space, appears to have benefited from the broad sector enthusiasm and validation that federal investment provides. The company's positioning in both quantum technology and commercial space applications aligns with two identified growth trends, making it a natural candidate for investor interest in the wake of this federal endorsement.

LIMN

Liminatus Pharma, Inc. Class A Common StockHealthcare

$0.25+$0.06

+31.0%

NASDAQ · Mkt cap $9.4 M

No news headlines were found in the last 48 hours to explain LIMN's 31% surge on May 21, 2026, making the specific catalyst unknown.

Yahoo Finance returned no recent headlines for Liminatus Pharma in the 48-hour window surrounding this significant price move. Without news reporting, we cannot identify a concrete catalyst such as clinical trial results, FDA decisions, partnership announcements, or earnings surprises. For a micro-cap biotech stock trading at $0.25, typical drivers of sharp single-day rallies include clinical data releases, regulatory approvals, financing announcements, or short-squeeze activity. It is also possible that a material announcement was made but has not yet been indexed by the RSS feed sampled, or that the move reflects technical trading or retail momentum in a highly liquid, low-priced equity. The absence of available news creates genuine uncertainty about causation.

NEOV

NeoVolta Inc.Industrials

$2.96+$0.70

+31.0%

NASDAQ · Mkt cap $214 M

No news was reported in the last 48 hours for NEOV, so the 31% gain is unexplained by published headlines. The move likely reflects technical trading, delayed news pickup, or speculative activity common in microcap stocks.

NeoVolta is a small-cap energy storage company, and no headlines from Yahoo Finance appeared in the last two days to explain the significant jump. In microcap stocks, large single-day gains often occur without contemporaneous news coverage due to low liquidity, thin float, and retail trading concentration. Possible catalysts include a press release not yet indexed by the RSS feed, a delayed market reaction to older news, technical breakout buying, or social media-driven speculation. Without access to the company's investor relations page or filing databases, we cannot confirm whether an earnings release, product announcement, partnership, or other material event occurred. The stock's rank as the 23rd biggest gainer suggests the move drew some attention but remains unexplained by the available headline data.

RGTI

Rigetti Computing, Inc.Technology

$22.04+$5.16

+30.6%

NASDAQ · Mkt cap $5.1 B

Rigetti Computing surged 30.57% on May 21 following the Trump administration's announcement of $2 billion in CHIPS Act grants to nine quantum computing companies, positioning Rigetti as a beneficiary of federal support and equity stakes in the sector.

The headlines establish that on May 21, 2026, the Trump administration awarded $2 billion in grants to quantum computing firms, with IBM receiving $1 billion and the federal government taking equity stakes across multiple companies. Rigetti is explicitly named in multiple sources as a quantum computing beneficiary rallying on this news. The sector-wide jump in quantum stocks (D-Wave, IBM, Rigetti all mentioned as gainers) reflects investor enthusiasm about federal validation, capital infusion, and competitive positioning against China. One headline directly attributes Rigetti's rise to prospects of a "more robust balance sheet" from the government backing. While the exact terms of Rigetti's specific award are not detailed in the provided headlines, the timing, sector catalysts, and consistent messaging across sources make the government funding announcement the clear driver of the 30.57% move.

FCEL

FuelCell Energy, Inc.Industrials

$26.38+$6.16

+30.5%

NASDAQ · Mkt cap $1.2 B

FuelCell Energy surged 30.46% following the announcement that cybersecurity entrepreneur and McKinsey veteran John Livingston joined the board of directors on May 19, marking the stock's sixth consecutive week of gains.

The primary headline establishing causation is the formal announcement on May 21 that John Livingston, with over 25 years of experience, has joined FCEL's board effective May 19. Board appointments by high-profile executives from prestigious firms like McKinsey can signal improved corporate governance, strategic direction, or potential business opportunities, which typically drives investor confidence in beaten-down stocks. A secondary headline from May 20 notes that hydrogen sector bulls were rotating into FCEL as the most undervalued name in the hydrogen complex, with the stock already up 15% that day. This suggests cumulative positive sentiment in the hydrogen sector preceding the board announcement. The company also announced Q2 2026 earnings will be released June 8, which is a standard procedural announcement. While the board addition is the most concrete news catalyst tied to May 21, the broader hydrogen sector rotation visible on May 20 indicates investor appetite was already building before this announcement.

NBIG

Leverage Shares 2x Long NBIS Daily ETF

$28.05+$6.35

+29.3%

NASDAQ

No news was reported in the last 48 hours, but NBIG is a 2x leveraged long ETF tracking NBIS, so a ~14.6% gain in the underlying index would mechanically produce this 29.26% move through leverage amplification.

Yahoo Finance returned no headlines in the last 48 hours for this security, so the price driver cannot be identified from news sources. However, NBIG's structure is crucial context. As a 2x long daily ETF, it is designed to deliver double the daily return of its underlying index NBIS. A 14.6% move in NBIS would naturally produce approximately a 29% move in NBIG through mathematical amplification rather than a separate catalyst. The underlying index itself may have gained on earnings from constituent companies, sector rotation, or broad market strength, but without access to NBIS-specific news or performance data, the precise cause of the underlying move cannot be determined. The leverage structure explains the magnitude but not the root catalyst.

NBIL

GraniteShares 2x Long NBIS Daily ETF

$40.05+$9.04

+29.2%

NASDAQ

No news headlines were found in the last 48 hours, but the stock is a 2x leveraged daily ETF on NBIS, so a strong move in the underlying would be amplified roughly twofold in this instrument.

Zero news headlines were provided for the 48-hour window. However, NBIL is structurally a 2x long daily leveraged ETF tracking NBIS, meaning it amplifies the daily moves of its underlying asset by approximately double. A ~15% single-day gain in NBIS would produce roughly a 29% move in NBIL, which matches the observed price action. Without access to NBIS news or intraday price data, the root cause likely stems from a significant move in the underlying equity—possibly driven by earnings, sector rotation, short covering, a corporate action, or other market-moving event affecting NBIS itself. The leverage mechanism explains the magnitude but not the underlying catalyst.

LNAI

Lunai Bioworks Inc.Healthcare

$0.29+$0.07

+29.1%

NASDAQ · Mkt cap $10 M

Lunai Bioworks announced a reverse stock split on May 20, which likely triggered the 29% single-day gain as investors reacted to the capital restructuring move.

The company announced a reverse stock split, though the headline was cut off before disclosing the exact ratio. Reverse splits are typically executed by companies whose stock has fallen to very low prices (LNAI is trading at $0.29) to improve per-share valuation metrics and restore compliance with exchange listing standards. The market reaction is mixed for reverse splits: some investors view them negatively as dilution masquerading as a reset, while others see them as necessary housekeeping that removes a technical overhang or signals management commitment to recovery. Given the stock's rank as the 28th biggest gainer today, the announcement appears to have triggered short-covering or technical buying in a micro-cap biotech stock where trading volume can amplify modest news into large percentage moves. Without knowing the split ratio or any accompanying strategic announcements, it is difficult to determine whether this reflects genuine optimism or purely technical repositioning.

AIXI

Xiao-I CorporationTechnology

$14.89+$3.28

+28.3%

NASDAQ · Mkt cap $654 K

No news headlines were found in the last 48 hours for AIXI, so the 28.25% gain cannot be attributed to a specific disclosed catalyst. The jump likely reflects technical trading, short covering, or delayed market reaction to untracked news.

Xiao-I Corporation (AIXI) posted a substantial single-day gain of 28.25%, ranking it among the top 29 gainers on NASDAQ, yet no relevant news articles appeared in the Yahoo Finance RSS feed within the preceding 48 hours. This disconnect between price action and visible headlines is notable. For a stock of this type, gains of this magnitude without announced catalysts typically stem from one of three scenarios: first, technical or momentum-driven buying (perhaps breaking a key resistance level or attracting algorithmic interest); second, short-squeeze dynamics if the stock has material short interest; or third, news that circulated through non-mainstream channels or was published outside the monitored news feed window. Without access to internal corporate announcements, regulatory filings, or social media activity, attribution remains speculative rather than evidence-based.

WHLRP

Wheeler Real Estate Investment Trust, Inc.Real Estate

$8.00+$1.75

+28.0%

NASDAQ · Mkt cap $4.6 M

No news headlines appeared in the last 48 hours, so the 28% gain cannot be attributed to a reported corporate event or market announcement. The move likely reflects technical trading activity, delayed news processing, or speculation in this thinly-traded real estate investment trust.

Wheeler Real Estate Investment Trust is a small-cap REIT with limited analyst coverage and trading liquidity, characteristics that can amplify price moves on modest volume. The absence of any news in the Yahoo Finance RSS feed over the last 48 hours suggests the rally was not driven by a major earnings release, dividend announcement, or operational update. Possible explanations include: first, a delayed market reaction to an older news item not captured in the 48-hour window; second, technical or short-covering activity in a stock with tight float; or third, sector rotation into undervalued REITs if broader real estate sentiment improved. Without headline confirmation, the specific catalyst remains unidentified.

WETO

Webus International Limited Ordinary SharesTechnology

$0.93+$0.20

+27.4%

NASDAQ · Mkt cap $11 M

Wetour Robotics announced a demonstration of cross-device AI agent control via a wristband interface integrated with Orchestra Edge AI Hub, aligning with emerging device-ecosystem trends and likely driving investor enthusiasm for the company's AI and IoT positioning.

The headline describes a concrete product demonstration by Wetour Robotics showcasing a Conductor sEMG wristband that enables touchless control across multiple device types including PCs, AR glasses, and IoT devices through an Orchestra Edge AI Hub platform. This announcement arrived on 2026-05-20, one day before the 27.4% jump on 2026-05-21. The timing and content suggest investors responded positively to evidence of working AI-agent technology in a competitive space where device-ecosystem integration is increasingly valued. The reference to Qualcomm CEO commentary on a shift toward agent-centric computing provides broader industry context reinforcing the relevance of Wetour's demonstration. However, the headline excerpt is truncated and does not clarify financial specifics, partnership scope, commercialization timeline, or revenue implications, so the depth of catalyst strength remains partially obscured.

AMCI

AMC Robotics CorporationTechnology

$5.55+$1.18

+27.0%

NASDAQ · Mkt cap $115 M

No news headlines were found in the last 48 hours, so the 27% jump in AMCI stock on this date lacks an identifiable public catalyst. The move may reflect technical trading, a delayed announcement, or rumors not yet captured in standard news feeds.

The absence of any news headlines in the Yahoo Finance RSS for the past 48 hours makes it difficult to pinpoint a specific driver for the 27% gain. For a small-cap robotics company like AMCI, typical catalysts that drive sharp single-day moves include contract announcements, guidance upgrades, insider transactions becoming public, sector-wide enthusiasm, or technical factors such as short covering and options expiration effects. Without access to the actual news, we cannot determine whether this was driven by a corporate announcement (M&A, partnership, earnings beat), sector momentum, or pure technical trading. The stock's relatively modest price point and rank as the 32nd biggest gainer suggest moderate volume participation rather than exceptional breadth.

DXYZ

Destiny Tech100 Inc.Financial Services

$61.66+$13.06

+26.9%

NYSE · Mkt cap $983 M

DXYZ surged 26.87% likely driven by momentum around the SpaceX IPO pre-trading opportunity on offshore crypto platforms, which aligns with the fund's mandate to track high-growth technology and space companies.

The single headline from the past 48 hours discusses an offshore crypto platform enabling early trading access to the anticipated SpaceX IPO, described as potentially the largest IPO in history. Destiny Tech100 is a venture capital-focused ETF that invests in pre-IPO and early-stage tech companies, with SpaceX as a known major holding. The news itself does not mention DXYZ explicitly, but the timing and thematic connection are direct: elevated investor interest and trading activity around SpaceX pre-IPO access would naturally benefit a fund with significant SpaceX exposure. This represents reasonable inference rather than confirmed causation, since the headline does not attribute the stock move to this news. However, no competing news or earnings catalysts are visible in the provided sources, making this the most plausible explanation.

RIBBR

Ribbon Acquisition Corp Rights

$0.25+$0.05

+26.8%

NASDAQ · Mkt cap $1.2 M

No news headlines were found in the last 48 hours, so the 26.77% gain in RIBBR rights shares likely stems from technical trading activity, SPAC-related developments, or market sentiment shifts that were not captured in standard news feeds.

Ribbon Acquisition Corp Rights are a special purpose acquisition company (SPAC) security with inherent structural characteristics that can drive price volatility independent of traditional news catalysts. Rights offerings are typically lower-priced and lower-volume securities compared to common shares, making them more susceptible to momentum trading, short covering, or rotation flows. The absence of news headlines does not rule out internal SPAC developments such as shareholder votes, merger negotiation updates disseminated via SEC filings rather than press releases, or technical trading patterns common to illiquid micro-cap securities. Additionally, this ranking as the 34th biggest gainer suggests broad market participation in a small-cap trade that could reflect sentiment shifts, options-driven hedging adjustments, or delayed market reaction to announcements made outside the 48-hour window.

SPOG

Leverage Shares 2x Long SPOT Daily ETF

$7.30+$1.53

+26.6%

NASDAQ

No news headlines were found in the last 48 hours to explain the 26.59% surge. SPOG is a 2x leveraged ETF tracking Spotify, so the jump likely reflects a significant rally in Spotify's stock price on an undisclosed catalyst.

The absence of news in the provided feed does not mean no catalyst exists; it means the headlines were not captured in this Yahoo Finance RSS snapshot. SPOG is a daily reset leveraged product with 2x exposure to Spotify (SPOT), which means a roughly 13% move in the underlying stock would produce approximately this 26% ETF move (before compounding effects). The most likely explanation is that Spotify experienced a significant positive catalyst today, possibly earnings, strategic announcement, analyst upgrade, market-wide tech rally, or competitive news. Without access to Spotify-specific headlines or market conditions on 2026-05-21, we cannot determine which. The leveraged structure amplifies whatever moved SPOT itself.

GCTS

GCT Semiconductor Holding, Inc.Technology

$3.45+$0.71

+25.9%

NYSE · Mkt cap $182 M

No news headlines were found in the last 48 hours, so the 25.91% gain likely reflects either a delayed market reaction to an earlier announcement, technical buying, or a private catalyst not yet widely reported.

The absence of any recent news headlines creates genuine uncertainty about the cause of GCTS's strong 26% intraday move. For a semiconductor holding company, typical catalysts would include earnings surprises, product announcements, partnership wins, or shifts in industry sentiment around chip demand. The stock's rank as the 36th biggest gainer suggests broad participation rather than a single shareholder action. Without access to press releases beyond the Yahoo Finance RSS feed, regulatory filings, or real-time market commentary, the most plausible scenarios are: first, a delayed market reaction to news released before the 48-hour window; second, technical momentum or short covering in a smaller-cap name; or third, an announcement made after market open that hasn't yet propagated to the headline feed. Semiconductor stocks have also been sensitive to AI demand expectations and geopolitical commentary, either of which could drive intraday moves.

ARQQ

Arqit Quantum Inc.Technology

$16.45+$3.36

+25.7%

NASDAQ · Mkt cap $375 M

Arqit Quantum released first-half fiscal 2026 earnings on May 21 showing higher revenue and increased commercial activity from government and defense customers evaluating post-quantum cybersecurity solutions, driving the 25.67% gain.

The timing and content of the news strongly support the price move. Arqit reported H1 2026 financial results alongside an earnings call highlighting two concrete positives: higher first-half revenue compared to the prior period and increased commercial activity from governments, telecom operators, and defense customers evaluating quantum-safe encryption solutions. The earnings call transcript snippet references momentum in 2025 around the growing recognition of quantum computing threats to data security. No specific revenue figures or profit metrics are visible in the provided headlines, so the magnitude of the beat or the exact nature of customer wins remain unclear. However, the combination of beating expectations on revenue, demonstrating real customer traction in a strategically important sector (post-quantum cybersecurity), and signaling healthy pipeline activity appears sufficient to justify a significant single-day move in a smaller-cap quantum tech stock where sentiment can shift sharply on narrative confirmation.

IONX

Daily Target 2X Long IONQ ETF

$70.89+$14.02

+24.7%

NASDAQ

No news headlines were found in the last 48 hours, but IONX is a 2X leveraged ETF tracking IONQ, so a significant move in the underlying quantum computing stock would be amplified roughly twofold in this product.

The absence of recent headlines makes it impossible to identify a specific catalyst from news sources. However, IONX's structure as a daily target 2X long leveraged ETF means it is designed to deliver twice the daily return of its underlying index or security. If the underlying IONQ quantum computing holdings or the broader quantum computing sector experienced a strong upward move—whether from a technical bounce, sector rotation, delayed announcement, or market sentiment shift—IONX would amplify that gain by roughly 2X. A 24.65% daily gain in a 2X leveraged product would imply roughly a 12% move in the underlying, which is plausible for a concentrated growth or technology sector ETF during normal trading conditions. Without news confirmation, the driver could be technical buying, options-related gamma, sector momentum, or an unindexed catalyst affecting quantum computing stocks.

IONL

GraniteShares 2x Long IONQ Daily ETF

$37.30+$7.27

+24.2%

NASDAQ

No news headlines were found in the last 48 hours, but the +24.21% surge in this 2x leveraged IONQ ETF likely reflects a sharp rally in the underlying IonQ stock, amplified by the fund's 2x daily leverage structure.

The absence of news in the headline feed does not mean no catalyst occurred; it may simply reflect a lag in news aggregation or the catalyst being announced outside the 48-hour window captured here. IONL is a leveraged ETF that aims to deliver 2x the daily return of IonQ, the quantum computing company. A 24% gain in IONL would imply roughly a 12% move in IonQ itself, which is substantial. This magnitude of move in a quantum computing stock could be driven by several factors: positive developments in IonQ's technology roadmap or commercial deals, sector-wide enthusiasm for quantum computing, short-covering, or delayed market reaction to an earlier announcement. Without specific news in the provided headlines, the precise catalyst remains unclear, though the leveraged structure confirms that whatever moved IonQ also moved IONL with amplification.

TDWDR

Tailwind 2.0 Acquisition Corp. Rights

$0.15+$0.03

+23.9%

NASDAQ

No news headlines were found in the last 48 hours. The 23.86% gain in this SPAC rights unit likely reflects either a delayed announcement, technical trading activity, or speculative positioning in a micro-cap security with low liquidity.

Tailwind 2.0 Acquisition Corp. Rights (TDWDR) is a SPAC rights unit, a security typically held by early SPAC investors that grants the right to purchase common shares upon merger completion or other triggering events. No news headlines were provided for the past 48 hours, so no specific corporate event can be identified as the direct cause of today's move. However, SPAC rights units are sensitive to several factors: announcements of merger targets or business combinations (even if released outside the 48-hour window), changes in deal likelihood or timing, shifts in redemption expectations, or redemption deadline approaches. Alternatively, this could reflect technical trading, short covering, or speculative activity common in micro-cap securities with thin trading volumes. Without accompanying news, attributing the move to a specific catalyst is not possible.

PHGE

BiomX Inc.Industrials

$0.74+$0.14

+23.8%

AMEX · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 23.79% gain in PHGE stock cannot be attributed to a specific announced event; the move likely reflects technical trading, short covering, or an untracked catalyst.

BiomX Inc. is a clinical-stage biotech company focused on phage therapy and microbiome treatments. No material headlines appeared in the Yahoo Finance RSS feed during the two-day window, meaning any major announcement either did not occur or was not captured by standard financial news sources. For a microcap biotech trading at $0.74, large single-day moves are common and can be driven by several factors typical to the category: a clinical trial announcement or interim data release not yet indexed in news feeds, short squeeze activity given the stock's likely low float and high short interest, technical bounce off support levels, or sector-wide momentum in biotech. Without concrete news, attribution to a specific catalyst is speculative.

AIB

BlockchAIn Digital Infrastructure, Inc.Technology

$2.20+$0.42

+23.6%

GOVX

GeoVax Labs, Inc.Healthcare

$2.75+$0.52

+23.3%

NASDAQ · Mkt cap $3.1 M

GeoVax announced on May 20 that its MVA-based vaccine platform could address the escalating Bundibugyo Ebola outbreak, positioning the company as a potential biodefense solution and driving a 23% gain.

The company issued a statement highlighting the relevance of its vaccine technologies to emerging hemorrhagic fever threats, specifically Ebola and Marburg viruses, in the context of a worsening Bundibugyo Ebola outbreak. For a small-cap biodefense company like GeoVax, public commentary linking its existing platform to an active, high-profile public health crisis can materially shift investor perception of commercial opportunity and near-term relevance. The timing of the announcement one day before the 23% move suggests investors interpreted this as a credibility signal or potential pathway to government contracts or expedited clinical interest. This is a reasonable inference for a company in infectious disease countermeasures, where real-world disease activity often catalyzes investor interest in related vaccine platforms. However, the headline does not confirm any new contract, funding, or partnership; it is commentary on existing technology relevance.

AGAE

Allied Gaming & Entertainment Inc.Technology

$0.61+$0.12

+23.2%

NASDAQ · Mkt cap $76 M

No news headlines were found in the last 48 hours for AGAE, so the 23.24% gain likely stems from technical trading activity, delayed news disclosure, or micro-cap volatility typical of penny stocks rather than a specific corporate catalyst.

The absence of any recent news headlines on Yahoo Finance within the 48-hour window makes it impossible to pinpoint a concrete catalyst for AGAE's strong intraday move. For a micro-cap stock trading at $0.61, price swings of this magnitude can occur from several sources: retail trader momentum, short covering, options expiration activity, delayed earnings or regulatory announcements not yet indexed by major financial news feeds, or simple liquidity-driven volatility. Without access to company filings, insider activity, or alternative news sources, attributing the move to a specific event is speculation. The stock's ranking as the 44th biggest gainer suggests it caught broad retail attention, but that itself may be a consequence rather than a cause of the price movement.

WYFI

WhiteFiber, Inc. Ordinary SharesTechnology

$29.55+$5.36

+22.2%

OTLK

Outlook Therapeutics, Inc.Healthcare

$0.33+$0.06

+22.0%

NASDAQ · Mkt cap $167 M

No news headlines were found in the last 48 hours, so the 22% intraday gain lacks a clearly identified catalyst; the move may reflect technical momentum, a delayed announcement, or sector rotation in biotech stocks.

Outlook Therapeutics is a clinical-stage biopharmaceutical company, and the stock jumped 21.98% to $0.33 on May 21, 2026, despite the absence of any news in the Yahoo Finance RSS feed over the preceding two days. This lack of headlines makes attribution difficult. For small-cap biotech stocks trading at this price level, common catalysts include clinical trial data releases, FDA decisions, partnership announcements, or restructuring events that may not always surface immediately in mainstream feeds. It is also possible the move reflects delayed dissemination of news from an earlier date, short covering if the stock is heavily shorted, or broader sector rotation into biotech. Without a specific documented event, the precise cause remains unclear.

Wheels Up Experience Inc.Industrials

$7.97+$1.42

+21.7%

NYSE · Mkt cap $175 M

No news headlines were found in the last 48 hours, so the 21.68% jump in UP stock lacks documented catalyst support and is most likely driven by technical trading, short covering, or untracked social media activity.

Wheels Up Experience is a fractional jet ownership and flight services company that filed for bankruptcy protection in 2023 and has since undergone restructuring. The stock trades with high volatility typical of distressed or recovery-story equities. With zero news headlines provided for the relevant 48-hour window, the substantial single-day gain cannot be attributed to earnings, guidance, partnerships, or operational announcements. This type of move in a micro-cap recovery stock is classically driven by short squeeze activity (retail coordination, margin calls forcing buy-ins), technical chart breakouts triggering algorithmic buying, or unvetted rumors circulating on social media platforms that do not appear in traditional financial news feeds. Without access to options flow, short-borrow data, or social sentiment metrics, the specific trigger remains speculative.

APLD

Applied Digital CorporationTechnology

$48.02+$8.50

+21.5%

NASDAQ · Mkt cap $7.1 B

Applied Digital signed a major 15-year multibillion-dollar AI infrastructure lease agreement with a hyperscaler, boosting total contracted revenue to $31 billion and surpassing 1 gigawatt of contracted capacity, directly catalyzing the 21.51% gain.

The headlines establish a clear, concrete catalyst: Applied Digital announced a new lease for its Polaris Forge 3 campus with a high investment-grade hyperscaler on a 15-year take-or-pay basis, adding significant contracted baseline revenue to the company's $31 billion pipeline. This milestone represents the company surpassing 1 gigawatt of contracted capacity across four AI Factory campuses. The deal was announced after market open on May 20 and trading on May 21 reflects the market's positive reception. The combination of a long-term, contracted revenue stream with a tier-one customer in the high-demand AI infrastructure market directly addresses investor concerns about revenue visibility and customer concentration. The stock had previously traded near $40 and extended to $44 on the announcement, with the 21.51% gain to $48.02 reflecting sustained momentum and likely some follow-on buying as the news circulated more broadly.

MNTS

Momentus Inc.Industrials

$7.55+$1.33

+21.4%

NASDAQ · Mkt cap $80 M

No news headlines were found in the last 48 hours, so the 21.38% jump cannot be attributed to any announced event. The move likely reflects technical trading, market sentiment shift, or an unindexed catalyst such as an internal announcement, analyst coverage, or short covering.

Momentus Inc. is a space logistics company that experienced a significant single-day rally with no corresponding news in the Yahoo Finance RSS feed over the prior 48 hours. This absence of headline support makes causation difficult to establish. Possible drivers include technical factors such as oversold conditions or a reversal pattern, sentiment-driven moves in small-cap space stocks, short squeeze activity if the company has material short interest, or an announcement made outside the indexing window captured here. Without visibility into intraday market data, social sentiment, or earnings calendars, we cannot identify the specific trigger.

RAIN

Rain Enhancement Technologies Holdco IncIndustrials

$2.45+$0.43

+21.3%

NASDAQ · Mkt cap $10 M

No news headlines were published about RAIN in the last 48 hours, so the 21% gain likely reflects either a delayed announcement, technical trading, or market rumor that is not yet captured in public financial news sources.

The absence of any recent headlines makes it impossible to identify a specific catalyst for the 21.29% jump on May 21, 2026. Without information about RAIN's business model, market capitalization, or trading patterns, reasonable hypotheses are limited. Small-cap stocks like those on NASDAQ sometimes experience sharp moves on minimal volume driven by momentum trading, short covering, or undisclosed corporate developments that surface first in alternative channels before reaching major news feeds. A delayed earnings release, clinical trial result, regulatory decision, or partnership announcement could explain the move but cannot be confirmed without evidence. The absence of news in the RSS feed does not prove no news exists; it may simply indicate a lag in indexing or that the catalyst emerged through less mainstream channels.

Biggest Losers

Thu, May 21, 2026 50

QBTZ

Defiance Daily Target 2X Short QBTS ETF

$5.04−$10.09

-66.7%

NASDAQ

No news headlines were found in the last 48 hours, but QBTZ is a 2X short leveraged ETF, so a 66.69% collapse most likely reflects a sharp rally in its underlying index, which would naturally crush a bearish leveraged fund.

QBTZ is structured as a daily target 2X short ETF, meaning it seeks to move -2X the daily performance of its underlying benchmark. When the underlying index surges sharply on a single day, a 2X short fund experiences compounded losses that can exceed 50% in extreme moves. The 66.69% single-day loss is consistent with a roughly +35% rally in the underlying index or a sustained rally over multiple days that has reset the fund's leverage. No news headlines were provided to confirm a specific catalyst for that underlying move, but leveraged inverse ETFs are inherently volatile and decay-prone instruments that respond mechanically to their benchmarks rather than to idiosyncratic company news. The absence of recent headlines suggests the move was driven by broad market momentum, index composition changes, or technical factors rather than a discrete corporate event.

RGTZ

Daily Target 2X Short RGTZ ETF

$4.79−$7.46

-60.9%

NASDAQ

No news headlines are available in the last 48 hours to explain the 60.90% drop. As a 2X short ETF, RGTZ loses value sharply when its underlying asset rises significantly, so the move likely reflects a strong rally in the underlying security rather than company-specific negative news.

No news headlines were found in the last 48 hours, so there is no direct announcement or event to point to as the cause. However, RGTZ is structurally a leveraged inverse ETF designed to move 2X in the opposite direction of its underlying asset. A 60.90% decline in a short ETF of this type typically results from a substantial rally in the underlying security itself, not from adverse news about RGTZ. The mechanism is straightforward: when the underlying asset rises sharply, inverse leveraged ETFs decay rapidly by design. Without access to the underlying security's name or recent price action, we cannot identify what triggered the underlying strength, but the magnitude of RGTZ's loss is entirely consistent with a major move upward in whatever equity or index it tracks.

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$0.45−$0.57

-56.2%

NASDAQ · Mkt cap $6.8 M

Digital Brands Group announced a strategic AI partnership with Renov AI on the day of the crash, but the announcement itself appears positive and does not explain the 56% plunge; the drop likely stems from a separate negative catalyst not captured in the provided headlines.

The most recent headline from May 21 describes a strategic partnership between Digital Brands Group and Renov AI to develop AI-powered commerce tools. This is framed as a positive announcement and would not logically trigger a 56% single-day collapse. The timing is suspicious—the announcement was made at 13:07 UTC on the same day as the massive drop, suggesting either the partnership was interpreted negatively by the market despite the bullish framing, or a separate material negative event occurred that is not reflected in the news provided. For a micro-cap apparel and e-commerce stock with a current price of $0.45, common catalysts for such severe drops include margin calls, debt covenant violations, insider selling, failed financing, operational disruptions, or undisclosed bad news. Without access to full market data or company filings released on May 21, the actual cause remains unclear. The provided headline does not explain the magnitude or direction of this move.

AMSS

AMASS Brands Inc. Common StockConsumer Defensive

$6.43−$4.87

-43.1%

NASDAQ · Mkt cap $11 M

AMASS Brands completed its Nasdaq direct listing on May 20, with the stock opening to trade under ticker AMSS and immediately falling 43% by the following day, suggesting a significant gap between listing price and market demand.

AMASS Brands announced completion of its Nasdaq direct listing on May 20, 2026, with trading under the new symbol AMSS commencing that day. The stock dropped 43% on or shortly after that announcement, making it the fourth-biggest loser on May 21. Direct listings typically price at an opening reference price determined by the underwriter and early trading; a sharp 43% decline the day after listing suggests either the opening reference price was set substantially above what the market was willing to pay, or broader negative sentiment emerged about the company's fundamentals, competitive positioning, or the beverage sector itself. The news headline does not provide information on the opening price, trading volume, market conditions, or any other contextual factors that would explain the magnitude of the decline. Without comparative data on typical direct listing price action or negative operational news, the most likely explanation remains a significant market repricing downward from the listing reference price.

GMM

Global Mofy Metaverse LimitedTechnology

$0.97−$0.47

-32.5%

NASDAQ · Mkt cap $5.3 M

GMM fell 32.51% with no news in the last 48 hours, making it impossible to pinpoint a specific catalyst; the drop likely stems from technical selling, market sentiment, or an untracked company announcement.

No headlines were available in the last 48 hours to explain GMM's sharp 32.51% decline. For a micro-cap metaverse-focused stock trading near $1, typical catalysts include sudden shifts in sector sentiment, execution delays in announced projects, untracked insider selling, dilutive financing announcements, or broad-based technical liquidation of speculative positions. Metaverse-related equities experienced significant volatility in 2024-2026 as investor enthusiasm waned from its 2021 peak. Without access to company press releases, SEC filings, or social media signals beyond the provided RSS feed, the exact trigger remains unclear. The stock's position as the fifth-biggest loser suggests either company-specific bad news or broad weakness in a particular sector cohort on that date.

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$1.97−$0.94

-32.3%

NASDAQ · Mkt cap $6.5 M

No news headlines were found in the last 48 hours, so the 32.30% drop cannot be attributed to a specific announced event; the cause likely involves technical selling, a delayed earnings announcement, insider activity, or other non-news-driven market factors.

The absence of any headlines in the most recent 48 hours is striking for a stock experiencing the sixth-largest single-day loss on the exchange. This suggests the catalyst was either pre-market, occurred outside normal news channels, or reflects a technical or sentiment-driven decline rather than a fundamental corporate announcement. For a stock trading at $1.97 on NASDAQ, common catalysts for such large moves absent headline news include delayed earnings or guidance announcements, insider selling disclosures, changes in analyst coverage or ratings downgrades distributed outside RSS feeds, broader sector rotation, or accumulated negative sentiment finally reaching a breaking point. Without access to SEC filings, earnings calendars, or real-time news sources beyond the provided RSS, the specific trigger cannot be determined from available evidence.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$3.17−$1.29

-28.9%

NASDAQ · Mkt cap $6.9 M

SUGP fell 28.92% despite announcing a Hong Kong government contract win that had driven a 20% surge the prior day, suggesting profit-taking after the initial rally or negative developments not captured in the provided headlines.

The timeline reveals a sharp reversal. On May 20, SUGP jumped 20% on news of a Hong Kong Civil Aviation Department contract award, a concrete positive development for an integrated security engineering services provider. However, by May 21, the stock had not only given back those gains but fallen an additional 28.92% from the previous close, landing it among the day's seven biggest losers. The provided headlines contain only the contract announcement and no subsequent negative news. This pattern is consistent with either aggressive profit-taking by investors who bought on the May 20 spike, or the emergence of material information (earnings miss, guidance cut, insider selling, regulatory issue, or deal-specific concerns) that occurred after the headlines were published but before market close on May 21. Without access to intraday developments or company statements issued after the contract announcement, the precise catalyst for the reversal remains unclear.

EMISR

Emmis Acquisition Corp. Rights

$0.10−$0.04

-28.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 28% decline in EMISR rights is unexplained by recent public announcements. The drop likely reflects typical volatility in SPAC rights or a delayed market reaction to an earlier event.

EMISR is a SPAC rights offering, which are structurally volatile securities with thin trading volumes and high sensitivity to shifts in investor sentiment toward blank-check vehicles. Rights themselves are derivatives—their value depends entirely on the underlying SPAC's near-term prospects for a merger or liquidation. Without published news in the last two days, the sharp drop could stem from several causes that are common to this asset class: liquidation pressure as the redemption or merger deadline approaches, deteriorating odds of a deal completing, forced selling by retail holders, or a significant move in the underlying common stock that wasn't captured in the news feed provided. It could also reflect delayed reaction to an announcement that occurred more than 48 hours ago. SPAC rights are particularly prone to sudden repricing on low volume.

FSHPR

Flag Ship Acquisition Corporation

$0.08−$0.03

-25.6%

NASDAQ

No news headlines are available in the last 48 hours to explain the 25.64% drop in FSHPR. The decline likely reflects either a delayed market reaction to prior events, technical selling pressure, or developments not yet captured in major financial news feeds.

Despite FSHPR ranking as the ninth biggest loser on the day with a significant single-day decline, no recent news articles appear in the Yahoo Finance RSS feed within the 48-hour window. This absence of headline-driven explanation is notable for a stock losing over a quarter of its value in one session. For a SPAC or acquisition-stage company like Flag Ship Acquisition Corporation, typical catalysts for sharp declines include failed merger negotiations, regulatory hurdles, shareholder vote outcomes, warrant exercises, or conversion mechanics that create dilution. Without access to those details or other company announcements, we cannot pinpoint the specific trigger. The move could reflect a delayed market response to news released earlier, technical liquidation, changes in investor sentiment around the broader SPAC sector, or private information not yet public.

IONZ

Daily Target 2X Short IONQ ETF

$2.88−$0.96

-25.0%

NASDAQ

No headlines were reported in the last 48 hours, but IONZ is a 2X leveraged short ETF on IONQ, so a 25% drop in IONZ likely reflects a sharp rally in the underlying IONQ stock, which would have gained roughly 12-13% today.

IONZ is structured as a daily target 2X inverse leveraged ETF tracking IonQ, meaning it moves in the opposite direction of IONQ with approximately double the magnitude. When the underlying IONQ stock rallies sharply, IONZ correspondingly declines. Without recent news headlines available, the exact catalyst for IONQ's apparent strong intraday gain cannot be identified from the information provided. The move could stem from quantum computing sector momentum, company-specific positive developments, technical buying, short covering, or broader market rotation into technology. Since IONZ amplifies inverse movements, even a moderate underlying advance produces a meaningful loss in this security. The lack of news does not mean no catalyst exists, only that it is not visible in the Yahoo Finance RSS feed provided.

QTEX

Inspira Technologies Oxy B.H.N. Ltd.Technology

$0.30−$0.09

-22.6%

NASDAQ · Mkt cap $50 M

QTEX fell 22.61% on a day when the company announced advanced discussions with a top-five quantum computing firm for strategic collaboration, suggesting market skepticism about deal timing, terms, or execution risk rather than enthusiasm for the partnership prospect.

The headline released on 2026-05-21 describes QTEX as being in advanced discussions with a major quantum computing company regarding strategic collaboration around its additively manufactured electronics and cryogenic interconnect technologies. This announcement would typically be viewed as positive news for a small-cap quantum hardware play. However, the stock dropped sharply the same day, ranking as the eleventh biggest loser. This disconnect suggests several non-mutually-exclusive possibilities. First, the market may have already priced in merger or partnership speculation and viewed the actual announcement as underwhelming relative to expectations, or the deal structure may appear dilutive to existing shareholders. Second, the headline is truncated and may contain material caveats or terms unfavorable to QTEX that are not visible in the snippet provided. Third, broader market factors, sector rotation, or technical selling in micro-cap stocks may be driving the decline independently of the news. Without access to the full press release or context on prior guidance, we cannot definitively establish causation between the announcement and the decline.

MGRT

Mega Fortune Company LimitedTechnology

$95.20−$27.29

-22.3%

NASDAQ · Mkt cap $1.3 B

MGRT dropped 22.28% on May 21, 2026, but no news headlines were available in the prior 48 hours to explain the move, making the cause unclear without additional information.

The absence of any news headlines in the 48 hours preceding this sharp 22.28% decline makes it impossible to pinpoint a specific catalyst from the evidence provided. A stock losing over a fifth of its value in a single day typically reflects a material negative event—such as an earnings miss, guidance cut, regulatory action, executive departure, or major customer loss. Without access to company filings, press releases, or broader market news from that date, we cannot distinguish between company-specific shocks and sector-wide or macro-driven declines. It is also possible that news broke after market close on May 20 or before market open on May 21, outside the RSS feed window captured here, or that the move was driven by technical factors or market sentiment shifts not reflected in traditional headlines.

YMAT

J-Star Holding Co., Ltd. Ordinary SharesBasic Materials

$0.49−$0.14

-22.2%

OCTVV

Octave Intelligence plcTechnology

$21.96−$6.04

-21.6%

NASDAQ · Mkt cap $4.4 B

No relevant news headlines appeared in the past 48 hours, so the 21.57% drop on OCTVV cannot be attributed to a specific company announcement or event based on available information.

The absence of news in the Yahoo Finance RSS feed over the last 48 hours means the decline cannot be tied to earnings, guidance, regulatory action, M&A, or other typical corporate catalysts. For a stock falling 21.57% in a single day without accompanying headlines, the most likely explanations fall into a few categories: delayed or embargoed news that has not yet propagated to major feeds, technical selling or forced liquidations unrelated to fundamentals, sector-wide weakness not captured in company-specific headlines, or a rumor or social media-driven move. Without access to real-time trading data, after-hours developments, or the full news landscape beyond Yahoo Finance RSS, we cannot pinpoint the specific trigger. The stock's rank as the 14th biggest loser suggests it was caught in significant selling pressure.

LICN

Lichen International LimitedIndustrials

$0.87−$0.22

-20.2%

NASDAQ · Mkt cap $21 M

LICN dropped 20% with no news in the last 48 hours, making the precise cause impossible to determine from available information.

No headlines were published in the last 48 hours surrounding this 20% intraday decline, so the catalyst cannot be directly attributed to any announced event, earnings release, regulatory action, or corporate development. For a micro-cap stock trading at $0.87, plausible explanations include delayed news disclosure from before the snapshot window, technical selling following a prior run-up, short-seller activity or allegations, insider selling, a missed financing milestone, or general liquidity-driven volatility typical of very low-priced securities. Without access to intraday or pre-market developments, trading halts, SEC filings, or social media sentiment, we cannot identify which of these categories is responsible. The absence of recent headlines does not mean nothing happened—only that no major news was captured in the Yahoo Finance RSS feed over the specified period.

INTU

Intuit Inc.Technology

$307.07−$76.86

-20.0%

NASDAQ · Mkt cap $91 B

Intuit plunged 20% after announcing a 17% workforce reduction and reporting slower-than-expected TurboTax sales growth, despite beating Q3 earnings estimates overall and raising full-year guidance.

The headlines establish two concrete negative catalysts. First, Intuit announced plans to cut approximately 17% of its workforce as part of a restructuring focused on AI, speed, and long-term growth. Second, while the company beat fiscal Q3 earnings expectations and raised fiscal 2026 guidance, TurboTax sales growth disappointed relative to consensus views. The layoff announcement appears to be the primary driver of the 20% decline, described as Intuit's worst single-day drop since 2003. This represents a classic market reaction where massive headcount reductions, even when coupled with upbeat earnings and guidance, trigger severe selloffs due to execution risk, near-term disruption concerns, and signal that management sees structural headwinds ahead. The TurboTax miss adds to the negative narrative by suggesting core business softness despite the AI opportunity angle mentioned by analysts.

BTM

Bitcoin Depot Inc.Financial Services

$0.58−$0.14

-19.1%

SATG

Leverage Shares 2x Long SATS Daily ETF

$18.91−$4.36

-18.7%

NASDAQ

No news headlines were reported in the last 48 hours, but the 18.74% decline in this 2x leveraged Bitcoin ETF most likely reflects a sharp drop in the underlying Bitcoin price, which would be amplified roughly twofold by the fund's leverage structure.

SATG is a 2x daily leveraged long ETF tracking Bitcoin (SATS). With no news headlines available to explain the move, the most probable cause is a significant decline in Bitcoin's spot price during the snapshot period. Because this fund uses 2x leverage on a daily reset basis, even a 9-10% drop in Bitcoin would mechanically produce approximately an 18-20% loss in the ETF's value, matching the observed decline closely. Leveraged ETFs are designed to amplify their underlying's daily moves in both directions, making them highly sensitive to the performance of their reference asset. Without access to Bitcoin's exact price action on May 21, 2026, or any news events tied to crypto markets, we cannot rule out intraday volatility, macro risk-off sentiment, or regulatory concerns affecting Bitcoin, but the mathematical structure of the product itself fully explains the magnitude of the move.

BIYA

Baiya International Group Inc. Ordinary SharesTechnology

$0.62−$0.13

-17.7%

NASDAQ · Mkt cap $71 M

No news headlines were available in the last 48 hours, so the 17.67% drop cannot be attributed to a specific public announcement or disclosed event.

BIYA dropped 17.67% on May 21, 2026, but no news was published in the prior 48 hours according to the Yahoo Finance RSS feed provided. This disconnect suggests either a delayed market reaction to older news, a technical or sentiment-driven selloff, a rumor not yet reflected in major news outlets, or order imbalances in a thinly traded micro-cap stock trading at $0.62. Penny and sub-dollar stocks are highly volatile and can gap sharply on volume spikes or short covering unrelated to company news. Without access to intraday volume, insider activity, or social media discussion, we cannot determine whether this was systematic selling, forced liquidation, or a technical breakdown.

YYGH

YY Group Holding LimitedIndustrials

$0.50−$0.11

-17.6%

NASDAQ · Mkt cap $4.5 M

YY Group announced the launch of OpenClaw agentic AI across Southeast Asia hotel clients on May 20th, but the stock fell 17.65% the next day, suggesting investors were disappointed by the announcement's scope, margin guidance, or competitive positioning despite the nominally positive news.

YY Group released two nearly identical press releases on May 20th announcing the rollout of its OpenClaw AI platform into hotel operations across Southeast Asia, emphasizing potential operating leverage and margin expansion. On the surface, a new product deployment with scaling potential should be viewed positively. However, the stock dropped sharply the following day, ranking among the day's twenty biggest losers. This suggests the market found the announcement underwhelming relative to expectations. Possible explanations include: the initial deployment scale was smaller than anticipated, management guidance on margin upside was conservative or unquantified, competitive threats were implied in the phrasing, or investor sentiment had already shifted bearish before the announcement. The headlines provided do not specify revenue commitments, customer counts, or timeline detail that would allow independent assessment of the business impact.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$5.90−$1.25

-17.5%

NASDAQ · Mkt cap $88 M

MWC fell 17.48% despite receiving Honda's "Excellent Appreciation Award" for development services, suggesting the market move was driven by factors unrelated to the positive news announcement.

The only headline provided is a positive recognition award from Honda Motor to Micware for outstanding development work in the automotive software space. This type of supplier award typically signals strong customer relations and quality execution, not a trigger for sharp sell-offs. The magnitude of the decline (17.48%, ranking 21 worst performer) and its timing same-day as the award announcement suggests either the market had already priced in or anticipated this award and sold on the news, or more likely the sell-off reflects a separate catalyst not captured in the news feed. Possible drivers include quarterly earnings disappointment, analyst downgrade, broader sector weakness in software development services, insider selling, or technical selling pressure. Without additional reporting, the gap between positive external recognition and sharp stock decline remains unexplained by the available headlines.

AREB

American Rebel Holdings, Inc.Consumer Cyclical

$0.05−$0.01

-17.2%

NASDAQ · Mkt cap $4.8 M

AREB fell 17% despite positive news on Indianapolis 500 activation, Capitol Hill meetings, and Total Wine partnership expansion, suggesting the decline was driven by factors unrelated to the announced developments or broader market/sector headwinds.

The headlines released over the past 48 hours describe what appear to be positive operational milestones for American Rebel Holdings: an Indianapolis 500 marketing activation, CEO meetings on Capitol Hill, a Total Wine partnership expansion, and statements about advancing national distribution. None of these reports contain negative guidance, missed targets, regulatory setbacks, or dilutive capital raises that would typically trigger a 17% single-day drop. The disconnect between constructive news and sharp price decline suggests the move was likely driven by factors outside the headlines provided. For a micro-cap beverage stock trading at $0.05, possible causes include profit-taking after a prior rally, sector rotation away from consumer discretionary, technical breakdown below key support, accumulating short pressure, or undisclosed insider selling. Without earnings data, insider transactions, or short-interest metrics, the precise catalyst remains unclear.

WGRX

Wellgistics Health, Inc.Healthcare

$0.11−$0.02

-17.1%

NASDAQ · Mkt cap $157 M

Wellgistics announced a reverse stock split on May 20, which typically signals financial distress and dilution concerns in penny stocks; this likely triggered the 17% single-day drop on the announcement news flow.

Wellgistics released three pieces of news within 48 hours: a reverse stock split announcement, a joint venture agreement with Datavault AI to form DelivMeds AI, and Q1 2026 financials showing pharmacy revenue growth from $0.1M to $0.6M month-over-month. While the revenue growth is positive, reverse stock splits are generally interpreted as negative signals by the market, particularly in micro-cap and penny-stock contexts, as they often precede further dilution, indicate a company's inability to maintain minimum price thresholds, or suggest financial instability. The joint venture announcement on the same day may have been intended as offsetting positive news, but reverse splits tend to dominate sentiment. The -17% drop on May 21 aligns with the May 20 reverse split announcement timing and appears to reflect market skepticism about the company's financial trajectory despite reported revenue improvements.

HLP

Hongli Group Inc.Basic Materials

$0.46−$0.09

-17.0%

NASDAQ · Mkt cap $90 M

HLP dropped 17% on May 21 with no material news released in the prior 48 hours, making the underlying catalyst unclear from available public information.

No headlines were found in the last 48 hours surrounding HLP's sharp 17% decline. This stock trades at a very low price point of $0.46, which typically indicates either a micro-cap, distressed, or heavily shorted name prone to volatility. Without news coverage, the move could reflect several plausible but unconfirmed drivers: a delayed or unindexed negative announcement from the company itself, deteriorating technicals or stop-loss cascades in a low-liquidity name, broader sector rotation, short-covering unwinding, or rumors in retail trading communities. The absence of headlines during such a significant move suggests either that financial news wires have not yet picked up the story, the catalyst is internal or rumor-based rather than official, or the move is primarily technical in nature.

DAVA

Endava plcTechnology

$3.34−$0.66

-16.5%

NYSE · Mkt cap $164 M

Endava reported Q3 fiscal 2026 results that missed revenue expectations and delivered significantly weak earnings, prompting management to lower fourth-quarter guidance amid delayed client decisions and extended sales cycles.

The headline evidence is unambiguous and comprehensive. Endava announced Q3 fiscal 2026 results on May 21, 2026 that fell short on both revenue and earnings fronts. The company missed revenue estimates by 3.64 percent and earnings estimates by a dramatic 74.27 percent. Multiple sources confirm management cited delayed client decisions, geopolitical disruption in the Middle East, and longer sales cycles as headwinds. The company also lowered its fourth-quarter outlook. While management attempted to frame a positive narrative around AI-driven transformation and strategic partnerships, the financial miss and reduced forward guidance appear to have overwhelmed any optimistic positioning. The 16.50 percent decline on the day aligns with reported drops ranging from 16 to 21 percent across the various headlines, suggesting the market reacted swiftly and uniformly to the disappointing earnings announcement.

SLS

SELLAS Life Sciences Group, Inc.Healthcare

$7.56−$1.41

-15.7%

NASDAQ · Mkt cap $2.8 B

SLS surged 18% yesterday on bullish cancer expansion news and FDA talk optimism, but the stock fell 15.72% today, likely due to profit-taking after the sharp one-day rally or delayed negative reaction to pipeline risk.

The available headlines from the last 48 hours describe positive catalysts: GPS (the company's therapeutic candidate) hit a 4-year high, the CEO signaled potential FDA discussions, and the stock rallied over 18% at yesterday's close on expansion prospects into up to 20 tumor types. However, today's 15.72% decline suggests either mechanical profit-taking after a sharp single-day gain or a delayed market reassessment of execution risk. Biotech stocks with early-stage pipeline expansion announcements are volatile; markets often buy the headline optimism aggressively and then sell when investors realize the company still faces years of clinical development, regulatory approval uncertainty, and manufacturing scale challenges. No fresh negative news is reported in the provided headlines, so the move appears to be a correction rather than a response to new information.

HSPT

Horizon Space Acquisition II Corp.Financial Services

$7.52−$1.38

-15.5%

WOK

WORK Medical Technology Group Ltd.Healthcare

$0.16−$0.03

-15.3%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 15.34% drop cannot be attributed to a specific announced event. The decline likely reflects broad sector weakness, technical selling, or unmonitoredoutside news flow for this micro-cap stock.

Yahoo Finance returned zero headlines for WORK Medical Technology Group Ltd. in the past 48 hours, despite a significant single-day loss that ranks it among the day's 28 biggest losers. Without news attribution, the cause remains speculative. For a low-priced micro-cap trading at $0.16, common catalysts include dilutive capital raises, insider selling, clinical setbacks in medical technology development, loss of a distribution partner, or deteriorating cash runway. Alternatively, the move could be technical—a break below support on low volume, or algorithmic selling in a thinly traded name. The absence of news does not rule out material developments; smaller stocks often have delayed or incomplete coverage on major financial news feeds.

AIIO

Robo.ai Inc.Consumer Cyclical

$3.23−$0.55

-14.6%

NASDAQ · Mkt cap $487 M

AIIO fell 14.55% despite positive news from subsidiary Neurovia AI about AI compression technology demonstrated at ISNR2026, suggesting the market sell-off was driven by broader sentiment or undisclosed catalysts rather than the announced achievements.

The two headlines from the past 48 hours both celebrate Neurovia AI's participation at ISNR2026 and its NeuroStream visual compression technology, framed as positive developments for the Robo.ai subsidiary. However, these announcements appear to have coincided with or failed to prevent a sharp 14.55% single-day decline, placing AIIO among the top 29 losers on NASDAQ. This disconnect suggests the market move was not directly triggered by the news provided. Possible explanations include broader market weakness in AI or data infrastructure stocks, negative analyst commentary or price target cuts not reflected in these headlines, profit-taking after a prior run-up, or undisclosed company-specific headwinds such as cash burn concerns, delayed revenue milestones, or competitive threats. Without additional context on valuation, insider trading, or sector rotation, the root cause remains unclear.

NYC

American Strategic Investment Co.Real Estate

$9.10−$1.54

-14.5%

NYSE · Mkt cap $22 M

No news headlines were found in the last 48 hours to explain the 14.47% drop in NYC stock, making the cause difficult to identify from available evidence.

American Strategic Investment Co. fell 14.47% to rank as the 30th biggest loser on the day, yet no recent news headlines are available to account for the move. This absence of reported catalysts makes determination of the cause challenging. For a closed-end fund or investment company like this, typical drivers of sharp declines include portfolio mark-downs due to broad market weakness, changes in net asset value relative to market price, dividend adjustments, or shifts in the fund's strategic positioning. Without access to earnings reports, management announcements, or market commentary from the past 48 hours, it is not possible to pinpoint which of these factors, if any, triggered today's decline. The move could reflect delayed reaction to earlier news, technical selling, or undisclosed developments.

OFIX

Orthofix Medical Inc.Healthcare

$10.41−$1.74

-14.3%

NASDAQ · Mkt cap $424 M

No news headlines were reported in the last 48 hours, so the 14.32% drop cannot be directly attributed to a disclosed event. The decline likely stems from technical selling, sector weakness, or delayed news not yet indexed.

Orthofix Medical is a mid-cap medical device company specializing in orthopedic and spine products. The absence of recent headlines in the last 48 hours makes it impossible to pinpoint a specific catalyst for the sharp decline. Medical device stocks are often sensitive to clinical trial results, reimbursement changes, competitive announcements, or shifts in healthcare spending sentiment. Given the magnitude of the move (14.32%), this would typically signal either a material negative announcement, insider selling, or short covering, but without corroborating news, these remain speculative. It is also possible that relevant news was published outside the indexed RSS feed window or that the move reflects broader sector headwinds in medical device equities on the snapshot date.

STAK

STAK Inc. Ordinary SharesEnergy

$1.10−$0.18

-14.1%

NASDAQ · Mkt cap $29 M

No news headlines were found in the last 48 hours for STAK, so the 14% decline today likely stems from broad market weakness, technical selling, or undisclosed company developments not yet reported by major outlets.

The absence of recent news makes it difficult to pinpoint a specific catalyst for today's sharp 14% drop in STAK stock. STAK is a micro-cap security trading near $1.10, which means it is typically subject to higher volatility and can move sharply on lower trading volume. The decline could reflect several categories of events: general market sell-offs affecting small-cap equities, profit-taking after prior gains, technical chart weakness triggering stop-losses, or delayed disclosure of adverse company news that has not yet surfaced in major financial media feeds. Without substantive headlines or structural insight into STAK's business, operations, or recent corporate actions, attributing the move to any specific event would be speculation rather than analysis.

CAPS

Capstone Holding Corp.Basic Materials

$0.33−$0.05

-14.0%

NASDAQ · Mkt cap $2.9 M

Capstone reported strong Q1 results with 60% revenue growth and best gross margin in four years on May 20, yet the stock fell 14% the next day, suggesting the market may have expected even stronger guidance, faced selling pressure on valuation concerns, or reacted to commentary beyond the headlin…

The headlines establish a genuinely positive earnings report: Q1 2026 revenue grew 60% year-over-year and gross profit surged 124%, with gross margin at a four-year high. By conventional metrics this should support or lift the stock. The 14% drop the following day is therefore counterintuitive. This pattern typically occurs when management guidance for forward quarters disappointed relative to analyst expectations, when the company disclosed margin pressure or revenue headwinds ahead despite strong current results, or when the market repriced the stock downward due to valuation concerns (i.e., the good results were already priced in). Without access to the full earnings release, guidance statements, or analyst sentiment, we cannot pinpoint whether the issue was guidance, commentary, or pure valuation rerating. A secondary possibility is that the stock declined due to macro factors or sector rotation unrelated to the earnings announcement itself.

INDP

Indaptus Therapeutics, Inc.Healthcare

$1.06−$0.17

-13.8%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours, so the 13.82% drop likely stems from technical selling, broader market weakness, or an unannounced development in this micro-cap biotech stock.

Indaptus Therapeutics is a small-cap biotech company with minimal news flow in the provided window. The absence of any headlines in the last 48 hours makes it impossible to point to a specific corporate catalyst such as clinical trial results, regulatory action, financing news, or management changes. For thinly traded micro-cap biotech stocks like INDP, sharp single-day declines often reflect one of several dynamics: sector-wide pressure on early-stage therapeutics, technical/liquidity-driven selling, short covering reversals, or unannounced private information that reaches the market before formal press releases. Without access to real-time trading data, social media signals, or insider filings, pinpointing the driver is speculative. The stock's rank as the 34th biggest loser suggests material selling pressure, but the cause remains opaque from available news sources.

YOOV

Concorde International Group Ltd.Industrials

$0.70−$0.11

-13.3%

NASDAQ · Mkt cap $139 M

No news headlines were found in the last 48 hours for YOOV, so the 13.31% decline on May 21, 2026 cannot be directly attributed to a specific announced event and likely stems from technical selling, sector weakness, or undisclosed market activity.

The absence of recent news in the Yahoo Finance feed means we cannot point to earnings, guidance, regulatory action, M&A, or other corporate-specific catalysts as the cause of today's drop. YOOV is a thinly-traded microcap security on NASDAQ, and such stocks are prone to sharp intraday moves driven by low liquidity, algorithmic trading, or broader sector rotation. It is also possible that relevant news exists outside the Yahoo Finance RSS feed, or that the move reflects delayed market reaction to older news, insider activity, or short-seller activity. Without either recent headlines or structural knowledge about the company's business, capital structure, or float, we cannot distinguish among these possibilities with confidence.

BVS

Bioventus Inc.Healthcare

$9.50−$1.45

-13.2%

NASDAQ · Mkt cap $980 M

BVS fell 13.21% on May 21, but the single available headline is a generic valuation question from Zacks with no concrete earnings, guidance, or news catalyst mentioned, leaving the specific trigger unclear.

The only headline provided is a Zacks article asking whether Bioventus is undervalued, which does not report any new information, earnings miss, guidance change, regulatory action, or material announcement. This appears to be a general commentary piece rather than breaking news. For a 13% single-day drop in a medical device or orthobiologic company like Bioventus, typical catalysts would include quarterly earnings misses, downward guidance revision, competitive setbacks, clinical trial failures, reimbursement cuts, or short-seller reports. Without access to intraday announcements or news outside the Yahoo Finance RSS feed provided, the specific trigger cannot be identified from the evidence at hand. The timing coincidence with a valuation question suggests either the article prompted selling or was published in response to the stock's decline.

RKLX

Daily Target 2X Long RKLB ETF

$80.33−$12.15

-13.1%

NASDAQ

No news headlines were found in the last 48 hours, but RKLX is a 2X leveraged long ETF on Rocket Lab stock, so a sharp decline most likely reflects a significant drop in the underlying RKLB stock, amplified by the fund's leverage structure.

The absence of news in the provided headlines does not explain the 13.14% single-day drop directly, but this security's structure is highly informative. RKLX is a daily target 2X long leveraged ETF tracking Rocket Lab (RKLB), meaning it amplifies daily price movements of the underlying stock by a factor of two. A 13.14% drop in RKLX would typically correspond to a roughly 6.5% to 7% decline in RKLB itself, depending on intraday volatility and fund fees. The most likely catalyst is therefore a sharp selloff in Rocket Lab stock on May 21, 2026, triggered by either company-specific news (earnings miss, guidance cut, contract loss, production issues) or broader market dynamics affecting aerospace and defense equities. Without access to RKLB-specific headlines or market conditions for that date, we cannot pinpoint the exact driver, only confirm that the leverage structure is working as designed to magnify the underlying move.

EZGO

EZGO Technologies Ltd.Consumer Cyclical

$1.75−$0.26

-12.9%

NASDAQ · Mkt cap $2.6 M

EZGO Technologies fell 12.94% on May 21, 2026, with no news headlines in the last 48 hours to explain the decline, leaving the catalyst unclear.

The absence of any headlines in the last 48 hours makes it impossible to identify a specific company-driven catalyst for this 12.94% drop. EZGO is a small-cap NASDAQ stock, and such names are susceptible to multiple potential pressures including sector-wide rotation out of micro-cap or growth equities, technical selling from profit-taking or chart breaks, broader market weakness that day, liquidity events, or undisclosed company developments that have not yet been reported by Yahoo Finance. Without access to real-time social media, institutional positioning changes, or delayed press releases, we cannot determine whether this was market-driven noise or a meaningful event.

ADTX

Aditxt, Inc.Healthcare

$1.22−$0.18

-12.9%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours, so the 12.86% decline cannot be attributed to a specific announced event; the drop likely reflects either technical selling, sector-wide weakness, or undisclosed company-specific developments.

Aditxt is a small-cap biotech company, and the absence of recent news headlines makes it impossible to identify a concrete catalyst for today's 12.86% decline. Small-cap biotechs are particularly sensitive to clinical trial updates, regulatory decisions, financing announcements, and shifts in sector sentiment around immunotherapy or diagnostic companies. The stock's low price of $1.22 suggests it may trade with limited liquidity and higher volatility. Without access to news, the decline could reflect a delayed response to an earlier announcement, broader biotech sector pullback, short-term technical selling, or private intelligence among insiders or investors that has not yet reached public headlines. It is also possible that material news exists but was not captured in the Yahoo Finance RSS feed provided.

JBDI

JBDI Holdings LimitedConsumer Cyclical

$0.51−$0.07

-12.8%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 12.78% decline cannot be attributed to a specific announced event. The drop likely reflects broader market sentiment, technical selling, or undisclosed company developments.

The absence of any news coverage in the last 48 hours makes it impossible to identify a definitive catalyst for JBDI's sharp decline. Micro-cap stocks like JBDI, trading at $0.51, are typically more susceptible to technical factors, including momentum-based selling, changes in trading volume, short covering reversals, or shifts in retail investor attention. Without access to real-time order flow data, SEC filings, insider transactions, or earnings reports released outside the monitored news feed, we cannot pinpoint whether this was driven by company-specific fundamentals, sector rotation, or purely technical momentum. The stock's ranking as the 40th biggest loser suggests it underperformed broader indices, but that alone does not explain causation.

CHCI

Comstock Holding Companies, Inc.Real Estate

$13.84−$1.93

-12.2%

NASDAQ · Mkt cap $195 M

Comstock reported strong Q1 earnings growth and announced summer events, yet the stock fell 12.24% same-day, suggesting the market either disappointed on guidance, valuation concerns, or an unrelated negative catalyst not captured in the headlines.

The headline evidence presents a puzzle. Comstock announced Q1 earnings that beat year-over-year on revenue and EPS, plus portfolio expansion and fee income growth, which are typically bullish catalysts. The company also announced Summerbration events at two properties, which are operational updates. None of these constitute obviously negative news. The 12.24% single-day drop ranks CHCI among the day's 41 biggest losers, which is material. Possible explanations include: (1) the earnings beat was smaller than expected or guidance was lowered for future quarters, information not reflected in the headlines provided; (2) valuation concerns in a rising-rate environment affecting real estate asset managers; or (3) an unrelated market or sector selloff in commercial real estate or mixed-use development stocks that day. Without full earnings release details or broader market context, the precise trigger remains unclear.

RDGT

Ridgetech Inc.Healthcare

$1.44−$0.20

-12.2%

NASDAQ · Mkt cap $2.9 M

No news headlines were found in the last 48 hours for RDGT, so the 12.2% decline cannot be directly attributed to a disclosed event. The move likely stems from technical selling, delayed news dissemination, or broader market conditions affecting small-cap stocks.

The absence of any Yahoo Finance headlines in the past two days makes it impossible to point to a specific catalyst for RDGT's sharp decline. For a micro-cap stock trading near $1.44, typical drivers of large single-day moves include earnings announcements (beats or misses), guidance changes, insider trading disclosures, shareholder dilution events, or sector-wide selloffs. It is also possible that news broke through other channels not captured by the RSS feed, or that the market reaction reflects accumulated concerns rather than a single discrete event. The stock's ranking as the 42nd biggest loser suggests this was a material one-day move, but without headline evidence we cannot distinguish between fundamental deterioration and technical or sentiment-driven selling.

SONM

DNA X, Inc.Technology

$3.94−$0.54

-12.1%

NASDAQ · Mkt cap $3.2 M

No news headlines were found in the last 48 hours, so the 12% drop likely reflects either a delayed market reaction to an earlier announcement, technical selling, or a sector-wide pullback unrelated to company-specific developments.

DNA X (SONM) dropped 12.07% to $3.94 with no identifiable news in the prior 48 hours according to the available feed. This disconnect between significant intraday movement and absence of fresh headlines suggests several possible causes. Biotech and specialty research stocks commonly experience sharp moves on clinical trial updates, regulatory decisions, partnership announcements, or shifts in sentiment around their core pipeline assets. The stock's relatively low price point ($3.94) and its appearance as the 43rd largest loser also hints this may be a micro-cap or penny-range security prone to higher volatility. Without access to broader market context, company announcements on other platforms, or pre-market news, it is difficult to pinpoint whether this reflects a delayed negative catalyst, profit-taking in a volatile holding, or a broader sector rotation. The absence of news does not rule out significant company developments; it only indicates they were not captured in the Yahoo Finance RSS feed during the stated window.

FOFO

Hang Feng Technology Innovation Co., Ltd. Ordinary SharesIndustrials

$2.01−$0.28

-12.0%

NASDAQ · Mkt cap $19 M

No news headlines were available in the last 48 hours to explain the 12.04% decline, so the cause remains unclear; the drop may reflect market-wide weakness, technical selling, or an unannounced catalyst.

The absence of recent news headlines in the Yahoo Finance RSS feed means there is no direct evidence of an earnings miss, product announcement, regulatory action, or other company-specific event that would typically explain a 12% single-day loss. FOFO, a Hang Feng Technology Innovation company traded on NASDAQ, could have experienced the decline for several reasons: broad market selloff affecting small-cap or China-exposed equities, technical breakdown through a support level, delayed filing or announcement not yet reflected in major news feeds, short-squeeze reversal if the stock had rallied previously, or investor reallocation away from lower-price-point positions. Without access to the company's filings, guidance, or real-time market data beyond the headline feed, attribution is speculative.

IGACR

Invest Green Acquisition Corporation

$0.15−$0.02

-11.7%

NASDAQ

No news headlines were published in the last 48 hours, so the 11.71% decline cannot be directly attributed to a reported event. IGACR is a blank-check acquisition company, making it highly sensitive to deal progress, timeline uncertainty, or redemption pressure.

The absence of recent news makes it impossible to pinpoint a specific catalyst for today's 11.71% drop. However, IGACR is a SPAC (special purpose acquisition company), a structure that depends entirely on investor confidence in management's ability to complete a merger or acquisition within a deadline. Common causes of sharp declines in SPACs include: (1) expiration or extension of the merger deadline without a signed agreement, which triggers automatic redemptions and shareholder uncertainty, or (2) negative developments in deal negotiations that may not yet be public but leak to insiders or short sellers. Additionally, SPACs often trade on technical factors and sentiment shifts. Without access to SEC filings, insider trading data, or social media chatter from the past 48 hours, we cannot distinguish between deadline pressure, deal fatigue, and pure technical selling. The stock's extremely low price of $0.15 suggests the company may be near its liquidation value, amplifying volatility.

PLUR

Pluri Inc.Healthcare

$2.30−$0.30

-11.5%

NASDAQ · Mkt cap $17 M

No news headlines were published in the last 48 hours for PLUR, so the 11.54% drop cannot be directly attributed to a disclosed catalyst. The move likely reflects technical selling, sector rotation, or undisclosed news flow.

Pluri Inc. experienced an 11.54% decline while ranking as the 46th biggest loser of the day, yet no material news headlines appeared in the last two days on Yahoo Finance. This disconnect suggests the stock was not driven by a major announcement, earnings release, or regulatory action that would have generated headlines. For a small-cap biotech or regenerative medicine company like Pluri, typical catalysts that move stock price include clinical trial results, partnership announcements, financing events, or shifts in competitive positioning. Without headline evidence, the decline could stem from broad sector weakness in biotech, technical selling pressure after recent strength, or a delayed market reaction to news not yet indexed by the RSS feed. Institutional or insider activity, rumor-based trading, or reversal of previous gains are also plausible but invisible in this snapshot.

FATN

FatPipe, Inc. Common StockTechnology

$3.79−$0.48

-11.2%

NASDAQ · Mkt cap $86 M

No news headlines were found in the last 48 hours, so the 11.24% drop cannot be attributed to a specific disclosed event. The move likely reflects either technical selling pressure, delayed market reaction to prior news, or a sector or company-specific rumor not yet captured in major news feeds.

The absence of recent news makes direct causation impossible to establish. FatPipe is a software networking company, and a single-day drop of this magnitude in a lower-volume NASDAQ stock can occur from several sources: profit-taking after a prior rally, sector rotation out of software or small-cap equities, options expiration mechanics, or an unconfirmed rumor circulating among traders before official disclosure. Without access to intraday trading volume, short interest spikes, or insider activity, we cannot distinguish between technical factors and a delayed reaction to material information that may be hours away from public confirmation. The fact that it ranks 47th among daily losers suggests this is part of a broader market pattern rather than an isolated stock event.

OSCG

Leverage Shares 2x Long OSCR Daily ETF

$17.04−$2.14

-11.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 11.16% drop was likely driven by a decline in the underlying OSCR security or broader market movement amplified by the 2x leverage structure of this ETF.

OSCG is a 2x leveraged long ETF tracking OSCR daily, meaning it amplifies the underlying security's moves by a factor of two. With no relevant news headlines available to explain the move, the decline almost certainly reflects a drop in OSCR itself or a broader market downturn affecting OSCR. A 5.5% decline in OSCR would produce roughly an 11% decline in OSCG due to leverage. Without knowing what drove OSCR lower, the most probable categories are sector rotation, company-specific developments not yet reflected in the news feeds provided, technical selling, or broader equity market weakness. The absence of news does not rule out an unannounced earnings miss, executive departure, or other material event; it simply means we lack documentation of it here.

SLE

Super League Enterprise, Inc.Communication Services

$4.97−$0.62

-11.1%

NASDAQ · Mkt cap $6.6 M

SLE fell 11.09% on May 21, but the two available headlines—one about Coach's former CEO and one announcing a new Roblox game partnership—do not explain the sharp decline. The drop appears disconnected from disclosed company news.

The two headlines provided are insufficient to account for an 11% single-day drop. The May 20 announcement about "Job City by Indeed on Roblox" is a product launch that appears positive and was released before market close, yet the stock dropped the following day. The May 21 headline about Coach's former CEO Lew Frankfort is entirely unrelated to SLE and appears to be a Yahoo Finance data error or misroute. For a micro-cap gaming and metaverse-focused company like Super League, typical catalysts for sharp moves include broader sector rotation out of metaverse/gaming plays, short covering reversals, options expiration effects, or undisclosed negative developments not yet reported in major outlets. Without additional context, the actual trigger remains unclear.

OSCX

Defiance Daily Target 2X Long OSCR ETF

$67.22−$8.37

-11.1%

NASDAQ

No news headlines were found in the last 48 hours, but OSCX is a 2x leveraged long ETF tracking OSCR, so a sharp underlying decline would amplify into an 11% drop. Market weakness in the underlying semiconductor or tech sector is the most likely driver.

OSCX is a daily target 2x leveraged long ETF tracking the Defiance OSCR index. Because it uses leverage to amplify daily returns, it is structurally sensitive to declines in its underlying index. An underlying drop of roughly 5-6% would mechanically produce an 11% fall in the leveraged fund, even without any news specific to OSCX itself. The absence of any headline in the 48-hour window suggests the move reflects broad market conditions or a decline in the OSCR index components rather than a company-specific or ETF-specific catalyst. OSCR tracks semiconductor or chip-related securities based on the ticker context, so sector weakness in that space is the most probable cause.